The G7 sensor uses an enzyme called glucose oxidase to continuously measure the concentration of glucose in this fluid
Many insurers have limited or even removed coverage of anti-obesity medications as demand has exploded, leaving consumers with high out-of-pocket costs
[1] Type 2 diabetes can lead to various complications, including heart disease, stroke, kidney disease, and blindness, so managing the disease is extremely important
Meanwhile, lower-income households, often located in regions with the highest obesity rates, face costs that place GLP-1s still firmly out of reach
Why GLP-1 Protocol Management Matters for Specialized Practices Integrative medicine clinics, functional medicine providers, med spas, DPC practices, and naturopathic clinics are increasingly offering GLP-1 programs